Jasper Therapeutics Inc (JSPR) is up Monday morning, with the stock climbing 3.13% in pre-market trading to 9.56. JSPR's short-term technical score of 21 indicates that the stock has traded less bullishly over the last month than 79% of stocks on the market. In the Biotechnology industry, which ranks 142 out of 146 industries, Jasper Therapeutics Inc ranks higher than 46% of stocks. Jasper Therapeutics Inc has risen 16.46% over the past month, closing at $7.81 on October 11. During this period of time, the stock fell as low as $7.21 and as high as $18.88. JSPR has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.
JSPR has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on JSPR!